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Abstract 
Background: Some clinical studies have suggested that ingestion of n-3 polyunsaturated fatty 
acids (PUFA) has neuroprotective effects on peripheral nerve function. However, few 
epidemiological studies have examined the effect of dietary n-3 PUFA intake from fish 
consumption on peripheral nerve function, and none have controlled for co-occurrence of 
methylmercury exposure from fish consumption.  
Objectives: We evaluated the effect of estimated dietary n-3 PUFA intake on peripheral nerve 
function after adjusting for biomarkers of methylmercury and elemental mercury in a 
convenience sample of 515 dental professionals. 
Methods: We measured sensory nerve conduction (peak latency and amplitude) of the median, 
ulnar and sural nerves and total mercury concentrations in hair and urine samples. We estimated 
daily intake (mg/day) of the total n-3 PUFA, n-3 docosahexaenoic acid (DHA), and n-3 
eicosapentaenoic acid (EPA) based on a self-administrated fish consumption frequency 
questionnaire. We also collected information on mercury exposure, demographics and other 
covariates. 
Results: The estimated median intakes of total n-3 PUFA, n-3 EPA, and n-3 DHA were 447, 105, 
and 179 mg/day, respectively. The mean mercury concentrations in urine (1.05µg/L) and hair 
(0.49µg/g) were not significantly different from the US general population. We found no 
consistent association between n-3 PUFA intake and sensory nerve conduction after adjusting for 
mercury concentrations in hair and urine although some positive associations were observed with 
the sural nerve.  
Conclusions: In a convenience sample of dental professionals, we found little evidence 
suggesting that dietary intake of n-3 PUFAs from fish has any impact on peripheral nerve 
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function after adjustment for methylmercury exposure from fish and elemental mercury exposure 
from dental amalgam.  
 
Abbreviations 
CMT-Charcot-Marie-Tooth 
CTS-Carpal Tunnel Syndrome 
DHA-Docosahexaenoic Acid 
DMA-Direct Mercury Analyzer 
EPA- Eicosapentaenoic Acid  
MDA- Michigan Dental Association 
NHANES- National Health and Nutrition Examination Survey 
TMDL -Theoretical Method Detection Limit 
PUFA-Polyunsaturated Fatty Acid 
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1. INTRODUCTION 
Dietary intake of n-3 polyunsaturated fatty acids (PUFAs), particularly from fish and 
shellfish, has been associated with a number of health benefits, including decreased risk of 
cardiovascular mortality and morbidity (Mozaffarian and Wu. 2011), ischemic stroke (He et al. 
2004) and cognitive decline (Morris et al. 2005). The evidence supporting neurological benefits 
of PUFAs is particularly strong for in utero and early neurodevelopment in infants (Birch et al. 
2007; Judge et al. 2007; Ryan et al. 2010). In addition, in vitro studies have shown that PUFAs 
have anticonvulsive properties that reduce arrhythmic transmembrane potential in neurons via 
modulation of voltage-dependent inactivation of sodium and calcium currents (Vreugdenhil et al. 
1996). Clinical studies that have examined the relationship between PUFAs and peripheral nerve 
function have also demonstrated neuroprotective effects of PUFAs. (Lauretani et al. 2007; Stiefel 
et al. 1999). 
Fish are a major dietary source of PUFAs, but fish are also the major source of exposure 
to methylmercury, a known central and peripheral neurotoxin.  Individual fish species vary in the 
content of PUFAs and methylmercury, so one’s pattern of fish consumption may have an 
important impact on the relative intakes of PUFAs and methylmercury (Mahaffey et al. 2008).  
As a result, the overall impact of fish consumption on peripheral nerve function may vary.  
Failure to account for methylmercury exposure as a confounder in evaluating the benefit of n-3 
PUFA has posed a challenge to the evaluation of the risks and benefits of fish consumption 
(Mahaffey et al. 2011).  Some studies have shown that failure to adjust for confounders may lead 
to underestimation of the beneficial effect of fish consumption (Choi et al. 2008) 
Furthermore, elemental (inorganic) mercury has been documented to be a peripheral 
neurotoxin, at least at high levels of exposure (Bluhm et al. 1992).  The major source of exposure 
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to elemental mercury in the general population is dental amalgam (Clarkson. 2002).  Previous 
studies that have examined the association of PUFAs and measured nerve function have not 
accounted for simultaneous exposure to methylmercury and/or inorganic mercury (Lauretani et 
al. 2007; Stiefel et al. 1999) 
In the present study, we evaluated the effect of estimated dietary intake of PUFAs from 
fish including total n-3 PUFA, 22:6 docosahexaenoic acid (DHA) and 20:5 eicosapentaenoic 
acid (EPA) on peripheral nerve conduction in a cohort of dental professionals, both before and 
after adjusting for biomarkers of exposure to methylmercury from fish and elemental mercury 
from dental amalgam.  
 
2. MATERIALS AND METHODS 
Participants were recruited during the Michigan Dental Association (MDA) annual 
conventions held in 2009 (n=232) and 2010 (n=283), as previously described (Wang et al. 2012). 
They represent a convenience sample of dental professionals attending the conventions. All 
participants provided written informed consent. The study was approved by the institutional 
review board of the University of Michigan. 
All participants completed a self-administered questionnaire to provide information about 
recent elemental mercury exposure from different sources (occupational practice and personal 
amalgams in the mouth), dietary fish consumption, medical history, demographics (race, gender, 
height, weight, age, occupation, hand dominance), and other covariates. We measured total 
mercury concentrations in urine and hair as biomarkers of exposure to elemental mercury and 
methylmercury, respectively (Clarkson. 2002). 
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2.1 Estimation of dietary intake of polyunsaturated fatty acids from fish 
We surveyed the average portion size and average monthly frequency of dietary 
consumption of 28 fish species within the six-month period prior to the date of the survey (See 
Supplemental Material, Table 1), using a scheme adopted from the NHANES Food Frequency 
Questionnaire 2003-2004 (Centers for Disease Control and Prevention (CDC). National Center 
for Health Statistics (NCHS). ). We also obtained species-specific concentrations of n-3 PUFA 
(See Supplemental Material, Table 1), including total n-3 PUFA, n-3 DHA, and n-3 EPA from 
the US Department of Agriculture National Nutrient Database for Standard Reference 
(http://www.nal.usda.gov/fnic/foodcomp/search/). We estimated daily intake (mg/day) of total n-
3 PUFA, n-3 DHA, and n-3 EPA from dietary fish consumption for each participant based on the 
following formula: 
[U*   P i * C i]/T   [1] 
U = average unit portion size of fish meals (g/portion) 
P i=frequency of eating a particular fish specie (portions/month) where i = 1, 2, 3…n and 
n = 28  
C i = species-specific average fatty acid concentration (mg/g) 
T = 30 (day/month) 
 
2.2 Urine and Hair Specimens 
All participants provided a spot urine sample in a mercury-free container (Becton, 
Dickinson, and Company; NJ, USA). A minimum of 10 mg (approximately 10-20 hair strands) 
of hair was collected from the occipital region of the head. We were not able to obtain urine and 
hair samples from 13 and 10 participants, respectively.  
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Total mercury content in urine and hair samples was determined using atomic absorption 
spectroscopy in the Direct Mercury Analyzer-80 (DMA-80, Milestone Inc., Shelton, CT) based 
on US Environmental Protection Agency Method 7473 as previously described by our laboratory 
(Paruchuri et al. 2010).  No hair or urine sample was below the Theoretical Method Detection 
Limit (TMDL), as previously described (Wang et al. 2012). 
 
2.3 Nerve conduction studies 
Nerve conduction studies, widely used in clinical practice and research to evaluate 
peripheral nerve function, have been used previously to assess subclinical peripheral nerve 
impairment related to low-level elemental mercury exposure from dental amalgam (DeRouen et 
al. 2006; Echeverria et al. 2005; Franzblau et al. 2012). Nerve conduction studies of sensory 
nerves, particularly in the lower extremity (e.g. sural nerve), are considered more sensitive for 
detecting subclinical changes than that of motor nerves in the upper extremity (e.g. median and 
ulnar nerves) (Kimura. 1984; Kingman et al. 2005). Thus, sensory nerve conduction studies can 
provide an objective and sensitive measure of change in peripheral nerve function as may occur 
in relation to dietary intake of n-3 PUFAs, methylmercury exposure from fish or elemental 
mercury exposure from dental amalgam at low concentrations relevant to the US general 
population. 
  Sensory nerve conduction studies were performed, including amplitude, onset latency and 
peak latency of the median and ulnar sensory nerves in the right wrist and the sural nerve in the 
right ankle. In general, higher amplitude and lower latency reflect better nerve conduction. The 
temperatures of the right midpalm and midfoot were recorded at the time of measurements. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
Hands and/or feet were warmed with electric heating pads if the limb surface temperature was 
initially below 32 °C.  
For measuring median and ulnar sensory nerves, antidromic stimulation was applied 
14cm proximal to standard ring-shaped recording electrodes, separated by a distance of 3cm and 
placed on digits II and V of the right upper extremity, respectively. A TECA Synergy (Oxford 
Instrument, Hawthorne, NY) was used to record the amplitude, onset latency and peak latency 
upon the stimulation over the median and ulnar sensory nerves. For measuring the sural sensory 
nerve, antidromic stimulation was applied on the posterior aspect of the right calf, 14cm 
proximal to the recording electrode placed behind the lateral malleolus in the lower extremity. 
The peak and onset latencies (milliseconds-ms) were defined as the time required for an 
electrical stimulus to initiate the first peak of an action potential waveform and the time to 
deflect from baseline of waveform, respectively. The amplitude (microvolts-µV) was defined as 
the baseline-to-peak voltage difference on a waveform. We took the best supramaximal 
stimulation of several trials for our amplitude measurements. 
We chose only to present amplitude and peak latency, but not onset latency because onset 
latency is highly correlated with peak latency, and measurement of peak latency tends to have 
better reliability than onset latency (Salerno D F et al. 1999). All parameters were recorded in 
accordance with the guidelines outlined by the American Association of Neuromuscular and 
Electrodiagnostic Medicine (American Association of Electrodiagnostic Medicine. 2002).  
 
2.4 Hand diagrams 
Participants also completed a self-administrated hand symptom diagram (Katz and Stirrat. 
1990; Katz et al. 1990). They were asked to shade the areas where numbness, tingling, burning 
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or pain had occurred more than three times, or lasted more than one week in the six months prior 
to the measurement. The diagrams were then reviewed and scored independently by two 
experienced raters for symptoms consistent with Carpal Tunnel Syndrome (CTS). Discrepancies 
were reconciled between the two raters through consensus. CTS symptoms were used as an 
exclusion criterion in the subsequent analyses.  
 
3. STATISTICAL METHODS 
3.1 Exclusions  
We excluded participants with self-reported conditions that may have an impact on nerve 
conduction and/or are related to mercury metabolism. As such, different exclusion criteria were 
applied to statistical models based on the specific variables involved in the analyses. In all 
analyses, we excluded one participant who reported Charcot-Marie-Tooth disease (CMT), three 
who were pregnant and four who reported chelation therapy in the last six months. 
When urinary mercury was included in a model, we excluded participants with 
preexisting kidney diseases (lithiasis, pyelonephritis, orthostatic proteinuria, end stage kidney 
disease or chronic renal failure). For modeling nerve conduction of the ulnar and sural sensory 
nerves accounting for urinary mercury, we additionally excluded participants with self-reported 
history of stroke or diabetes. For modeling nerve conduction of the median sensory nerve 
accounting for urinary mercury, we additionally excluded participants with a self-reported 
history of CTS or rheumatoid arthritis along with those diagnosed with CTS from the hand 
diagram.  
For modeling the ulnar or median sensory nerves accounting for hair mercury, 
participants with stroke, diabetes or preexisting kidney diseases were excluded in addition to the 
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exclusion of those who reported CMT, chelation or pregnancy. For the median nerve accounting 
for hair mercury concentration, participants with a self-reported history of CTS or rheumatoid 
arthritis along with those diagnosed with CTS from the hand diagram were excluded. As a result, 
the final sample sizes for modeling the median, ulnar and sural nerves were 406, 416 and 416, 
respectively.  
 
3.2 Descriptive analyses 
Descriptive analyses were carried out for BMI, age, occupation, and race (Caucasian and 
non-Caucasian) along with estimated daily intake of total n-3 PUFA, n-3 EPA, n-3 DHA and 
mercury biomarker concentrations as reflected in urine and hair mercury after excluding 
participants with stroke, diabetes, or preexisting kidney diseases. We compared mercury 
concentrations in urine and hair with reference concentrations as reported in the National Health 
and Nutrition Examination Survey (NHANES) using t-tests.  
 
3.3 Regression analyses 
Multivariate regression analyses were conducted in three phases for log-transformed 
nerve conduction measurements, as both latency and amplitude of all the nerves were not 
normally distributed. In the first phase, we developed base models that included all significant 
covariates associated with nerve conduction (See Supplemental Materials, Table 2). Specifically, 
each log-transformed nerve conduction measurement was regressed against covariates including 
race, gender, height, weight, age, occupation, dominant hand, and hand/foot temperature. The 
base model predicting nerve conduction was then found by retaining the statistically significant 
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predictors (p<0.05). As such, we established a total of six base models for amplitude and peak 
latency of the median, ulnar and sural nerves. 
In the second phase, we first added mercury concentrations in hair and urine (individually 
and together) to the six base models, for a total of 24 models. This gave us 4 models (a model 
without biomarkers, a model with urine mercury, a model with hair mercury and a model with 
both urine and hair mercury) for each of the 6 nerve function measures. Finally, we separately 
added total n-3 PUFAs, n-3 EPA, and n-3 DHA to each of the 24 models 
 
3.4 Sensitivity analyses 
Sensitivity analysis was performed for all models. A participant was considered a 
potential influential observation if the absolute value of the DFBETA statistic of a biomarker 
variable (either urine or hair mercury biomarker) or fatty acid variable (total PUFA, DHA or 
EPA) in relation to the respective modeled nerve conduction outcome was equal to/greater than 
the conventional cutoff value (2/sqrt (regression model sample size)). These influential 
observations were ranked in descending order according to the DFBETA statistics and were 
excluded if the Cook’s D statistic of the observations exceeded the conventional cutoff value (4/ 
(regression model sample size)). In cases where sensitivity analysis changed parameter direction, 
magnitude or statistical significance, we individually investigated influential observations for 
validity of exclusion. All statistical analyses were performed in SAS 9.2 (SAS Institute Inc., 
Cary, NC) and estimates with a two-sided p-value less than 0.05 were considered significant. 
 
4. RESULTS  
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The total sample included 515 participants and after excluding participants with stroke, 
diabetes or preexisting kidney diseases, the sample included 483 participants. Participants were 
predominantly Caucasian (n=439; 90.9%). Dentists comprised 47.2% (n=228) of the sample and 
95.3% (n=242) of the non-dentists were female (Table 1). Dentists were significantly older than 
non-dentists. 
The median estimated intakes of total n-3 PUFA, n-3 EPA, and n-3 DHA from fish were 
447, 105, and 179 mg/day, respectively (Table 2). These intakes were comparable to a modest 
intake of fatty acids (e.g. 250 mg/day EPA and DHA) as reported in a meta-analysis of health 
benefits of fish consumption (Mozaffarian and Rimm. 2006). Estimated total n-3 PUFA, n-3 
DHA, and n-3 EPA intake from fish had modest correlations with measured hair mercury 
concentrations (r=0.43, 0.47, and 0.42, respectively; See Supplemental Materials, Figure 1).  
The geometric mean and distribution of urine or hair mercury were similar to the US 
general population as reported in NHANES 2003-2004 (Centers for Disease Control and 
Prevention (CDC). ) and 1999-2000 (McDowell et al. 2004), respectively (Table 2). 
Adjusting for covariates associated with nerve conduction (See Supplemental Materials, 
Table 2), mercury concentrations in hair were associated with increased amplitude of all nerves 
measured as well as decreased sural peak latency; the directions of these associations were 
opposite to what was expected. Mercury concentrations in urine were associated with decreased 
amplitude of the median and ulnar nerves and increased peak latency of the ulnar nerve; the 
directions were as expected, but they were not statistically significant. 
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Subsequently we examined n-3 PUFA after adjustment for mercury concentrations in hair 
and/or urine. We found that increased intakes of total n-3 PUFA, n-3 EPA, and n-3 DHA were 
associated with better nerve conduction (decreased peak latency and/or increased amplitude) in 
the sural nerve but not all the associations were statistically significant (Table 3). Increased 
intakes of total n-3 PUFA and n-3 DHA were associated with improved median amplitude but 
not peak latency, and the associations were not statistically significant. Sensitivity analyses did 
not materially change the results.  
 
5. DISCUSSION 
In a range of consumption that reflects the general US population, we found little 
evidence that estimated dietary intake of total n-3 PUFA, n-3 EPA, and n-3 DHA from fish has 
beneficial effects on sensory nerve conduction with or without adjustment for biomarkers of 
exposure to methylmercury and/or elemental mercury. However, we found dietary intake of total 
n-3 PUFA, n-3 EPA, and n-3 DHA may improve sural amplitude and latency, although results 
were not all statistically significant.  
The nerve conduction results for the median and ulnar nerves in our study were within 
the range of the normative values previously reported in workers (Salerno D F et al. 1998). The 
sural nerve values were also within the normal range (Schuchmann. 1977). Coefficients of 
covariates, such as age, gender, height, weight, and skin temperature, were all similar in 
magnitude and direction to those reported in prior studies (Fujimaki et al. 2009; Greathouse et al. 
1989; Kimura. 1984; Letz and Gerr. 1994; Rivner et al. 2001; Robinson et al. 1993; Salerno D F 
et al. 1998; Tong et al. 2004; Trojaborg et al. 1992; Werner and Franzblau. 1996; Werner. 2006).  
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Rat studies have shown that treatment with both omega-6 and omega-3 fatty acids did not 
change peripheral sensory and motor nerve conduction in normal rats (Dines et al. 1993). Some 
studies have reported beneficial effects of n-3 PUFAs including accelerated neuron growth and 
recoveries from neurological injury (Dyall and Michael-Titus. 2008), but these protective effects 
were exclusive to the central nervous system.   
Human evidence regarding the effect of n-3 PUFAs on the peripheral nervous system has 
been limited.  In a recent clinical case study of peripheral nerve conduction, a patient with carpal 
tunnel syndrome was found to have improved sensory nerve conduction after being given daily 
oral doses of omega-3 oil (Ko et al. 2010), but the doses given were 10 times higher than the 
estimated daily dietary intake found in the present study. Stiefel et al. (1999) investigated the 
association between the diet of 18 type-I diabetic patients supplemented with n-3 PUFAs for 90 
days and changes in nerve conduction velocity (NCV) and amplitude in four nerves (median 
motor, median sensory, peroneal and sural nerves). The diet supplemented with n-3 PUFAs was 
found to be associated with improvement of median motor nerve conduction velocity. In a study 
of aging, Lauretani et al. (2007) measured baseline NCV and compound muscle action potential 
(CMAP) of the peroneal nerve among 1260 participants, 827 of which had repeated 
measurements after three years of follow-up. They found that measured PUFAs (omega-6 fatty 
acids, linoleic acid, arachidonic acid, omega-3 fatty acids, EPA, DHA and ratio of n-6/n-3) were 
not associated with baseline CMAP but omega-6 and linoleic acid were associated with baseline 
NCV. Among subjects followed for three years, the results were mixed: 17 of 66 models found 
significant associations, though some were in opposite directions. In both studies, the 
associations were not adjusted for mercury exposure and change in limb temperature between 
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measurements, which is an important confounder in prospective studies of nerve function (Tong 
et al. 2004; Werner et al. 2012). 
We found that n-3 PUFA intake from fish may have a beneficial effect on sensory nerve 
conduction of the sural nerve after adjustment for mercury exposure from fish and dental 
amalgam although the associations were not always statistically significant.  With a longer axon 
compared to the median and ulnar nerves, the sural nerve may be more susceptible to damage 
induced by mercury exposure from fish and dental amalgam and/or protective effects from n-3 
PUFA intake. It is biologically plausible for n-3 PUFA at a dose level relevant to the general 
population (e.g. 100-600 mg/day) to protect the peripheral nervous system against mercury 
toxicity via inhibition of axonal degeneration and/or myelinogenesis. Mercury has been shown to 
cause axonal degeneration (Heidemann et al. 2001; Wilke et al. 2003) and demyelination (Goetz. 
2010). However, our results suggest that if there are protective effects of n-3 PUFAs (with 
adjustment for mercury exposure), these effects are at most small at levels of fish consumption 
that are relevant to the general US population. 
The study has limitations. First, the study has a modest sample size of dental 
professionals available for analysis. Second, our study group was a convenience sample, not a 
random sample. However, there was no reason to believe that participants had any prior 
knowledge of their measured nerve function, mercury concentrations, or PUFA intake. 
Nevertheless, convenience samples may have other hidden biases. In addition, the choice of 
study population was determined partly by previous publication hypotheses of looking at effects 
of mercury exposure (particularly elemental mercury) and peripheral nerve function (Wang et al. 
2012). However, the distribution of PUFAs and mercury levels are wide and comparable to the 
general population. Third, PUFA intake was not measured but estimated from survey questions 
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of fish consumption. This may have led to recall and/or misclassification biases, but the 
questionnaire we used has been widely applied by NHANES and has been used in previous 
studies (Mahaffey et al. 2008). Also, the estimated PUFAs do not include non-fish dietary 
sources such as supplements or omega-3 enriched eggs. This might lead to underestimation of 
the PUFA levels in our population. Fourth, other possible toxins from fish consumption, such as 
dioxins, were not adjusted in the analyses due to data unavailability. Fifth, mercury measured 
from the 2 cm of hair closest to the scalp only reflects the most recent two months of 
methylmercury exposure from fish.  The questionnaire examined fish consumption during the six 
months prior to the survey and an unbiased reflection of fish methylmercury intake in hair 
mercury was dependent upon a steady-state body burden of methylmercury. Fish consumption 
may have fluctuated in the months prior to the survey. However, such fluctuation would likely 
bias the results towards the null as fish consumption may increase or decrease prior to two 
months before the survey. Sixth, day-to-day variability in urinary mercury excretion has been 
reported to average 22% among samples taken on three consecutive days (Ellingsen et al. 1993). 
However, this magnitude of variation is modest and the likely impact would be to bias the results 
towards the null. Seventh, misclassification of elemental mercury exposure might occur when 
urine mercury level is used as the biomarker because previous studies have shown that 10% or 
less of the total elimination of methylmercury also occurs in urine (Clark 2002). However, such 
misclassification is not likely to change the main results as shown in Table 3 because the effect 
of methylmercury was not significant in model 3 (with adjustment of hair mercury alone) across 
the board neither were the effects of methylmercury and elemental mercury when both were 
accounted for in model 1.  
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Despite the limitations, the study has strengths. It is the first to evaluate the effect of 
estimated PUFA intake from fish consumption with simultaneous adjustment for methylmercury 
and elemental mercury on peripheral nerve function using sensory nerve conduction, which is a 
sensitive and objective measure that can assess subclinical changes in nerve function. Further 
research is warranted preferably with direct measurement of fatty acids. 
 
6. CONCLUSIONS 
We found little evidence that n-3 PUFA from dietary fish consumption including total n-
3 PUFA, n-3 DHA, and n-3 EPA improves sensory peripheral nerve conduction in a convenience 
sample of dental professionals exposed to levels of elemental mercury and methylmercury that 
are relevant to the general US population. The results suggest that the potential benefit of n-3 
PUFA from fish on peripheral nerve function are at most small in dental professionals at levels 
of consumption that are relevant to the general US population. 
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Tables: 
Table 1: Demographics 
    N   Age (year;SD) 
BMI 
(kg/m
2
;SD) Female 
Occupation      
 Dentist 228  56.0 (11.4) 
a
 26.3 (3.9) 55 (24.1%) 
 Non-dentist 254  47.8 (11.3) 
a
 26.3 (5.2) 242(95.3%) 
       
 Subtotal 482    297 (61.6%) 
       
 Missing 1    1 
       
Race      
 Caucasian 439  52.2 (12.0)
 b
 26.2 (4.4)  
 Non-caucasian 43  45.9 (12.2)
 b
 27.3 (6.3)  
       
 Subtotal 482     
       
  Missing 1         
a
T-test, p<0.005; 
b
T-test, p<0.0001  
SD: standard deviation 
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Table 2: Mercury concentrations in urine and hair and intake of total n-3 PUFA, n-3 EPA, and n-3 DHA 
  N Geometric mean Arithmetic mean Median 25% 75% 90% 95% 
Urine Hg (µg/L) 471 0.65
a
 1.05 0.66 0.32 1.30 2.35 3.66 
Ref:NHANES (2003-04)  1529 0.50
a
 0.95
c
 0.48 0.19 1.12 2.20 3.33 
         
Hair Hg (µg/g) 474 0.28
b
 0.49 0.29 0.14 0.58 1.16 1.43 
Ref:NHANES (1999-00) 1926 0.12
b
 0.47 0.19 0.09 0.42 1.11 1.73 
         
Total n-3 PUFA (mg/day) 482   520 927 447 64 1199 2340 3697 
n-3 EPA (mg/day) 482 116 208 105 16 274 539 830 
n-3 DHA (mg/day) 482 206 343 179 40 437 866 1213 
a
 T-test, p=0.19 
b
 T-test, p=0.29 
c
 calculated using NHANES (2003-04) data (CDC 2009) 
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Table 3: Effects of total n-3 PUFA, n-3 EPA, and n-3 DHA intake on sensory peripheral nerve conduction adjusting for mercury concentrations in urine and/or 
hair 
Nerve conduction 
(Units) 
Nerve Model N Coefficient (x10
-6
) 
   
 
Total n-3 PUFA 
n-3 
EPA 
n-3 
DHA 
Log-transformed Peak 
latency (ms) 
Median 0 396 3.8  17  6.7 
 1 384 75 34  18 
 2 390 4.3  20  8.2 
  3 390 7.2  32  17 
 Ulnar 0 406 2.8 13 7.4 
  1 394 5.3  24 16 
  2 400 2.4  11 5.8 
  3 400 5.2  23 16 
 Sural 0 365 -5.5  -24 -16 
  1 354 -1.2  -5.3 -1.3 
  2 359 -4.9  -21 -14 
  3 360 -1.5  -6.4 -2.3 
       
Log-transformed 
Amplitude (µV) 
Median 0 396 12  52 38 
 1 384 0.4 -0.8 0.5 
  2 390 14 60 46 
  3 390 1.2 3.6 2.2 
 Ulnar 0 406 8.5 35 29 
  1 394 -2.4 -14 -7.1 
  2 400 9.9 41 34 
  3 400 -2.6 -14 -8.2 
 Sural 0 398 39
a
 170
a
 120
a
 
  1 386 28 130 85 
  2 392 39
a
 180
a
 120
a
 
  3 392 26 120 78 
Model 0: one micronutrient in each model without adjusting for mercury concentrations 
Model 1: one micronutrient in each model adjusting for mercury concentrations in urine and hair 
Model 2: one micronutrient in each model adjusting for mercury concentrations in urine 
Model 3: one micronutrient in each model adjusting for mercury concentrations in hair 
a
 p<0.05; All models were adjusted for other covariates (age, gender, BMI, weight, height, limb temperature, dominant hand) as shown in Supplemental Table 2
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Highlights 
-Few studies have examined effect of dietary n-3 PUFAs on peripheral nerve function 
-No study controlled for methylmercury from fish and elemental mercury from amalgam 
-We found no effect of n-3 PUFAs on nerve function adjusting for mercury biomarkers 
Supplemental Materials - Page 1 of 4 
Online Supplemental Materials: 
Supplemental Material, Table 1: Summary of average micronutrient concentrations in fish species 
Fish Species 
Average total 
PUFA 
concentration (mg 
PUFA/g fish) 
Average EPA 
concentration 
(mg EPA/g 
fish) 
Average DHA 
concentration 
(mg DHA/g fish) 
Source 
Tuna White(canned in water) 11.09 2.33 6.29 USDA National Nutrient Database 
Tuna Light(canned in water) 3.37 0.47 2.23 USDA National Nutrient Database 
Tuna Fresh (yellowfin, raw) 1.47 0.12 0.88 USDA National Nutrient Database 
Salmon 38.86 8.62 11.04 USDA National Nutrient Database 
Shrimp 1.3 0.3 0.31 USDA National Nutrient Database 
Cod 2.31 0.64 1.2 USDA National Nutrient Database 
Crab 1.3 N/A N/A USDA National Nutrient Database 
Scallop 1.3 0.42 0.61 USDA National Nutrient Database 
Mussel 6.06 1.88 2.53 USDA National Nutrient Database 
Halibut 2.9 0.66 1.28 USDA National Nutrient Database 
Lobster 5.9 2.65 1.08 USDA National Nutrient Database 
Clam 1.92 0.43 0.64 USDA National Nutrient Database 
Oyster 5.91 1.88 2.03 USDA National Nutrient Database 
Perch 3.04 0.79 1.74 USDA National Nutrient Database 
Perch Freshwater N/A N/A N/A USDA National Nutrient Database 
Trout 15.07 2.17 5.16 USDA National Nutrient Database 
Carp 14.31 2.38 1.14 USDA National Nutrient Database 
Walleye 4.47 0.86 2.25 USDA National Nutrient Database 
Seabass 7.43 1.61 4.34 USDA National Nutrient Database 
Fresh Seabass 10.62 2.38 3.57 USDA National Nutrient Database 
Pike 2.02 0.33 0.74 USDA National Nutrient Database 
Swordfish 11.47 1.07 6.47 USDA National Nutrient Database 
Red Snapper 4.59 0.51 2.6 USDA National Nutrient Database 
Shark 11.95 3.16 5.27 USDA National Nutrient Database 
King Mackerel 4.6 1.36 1.77 USDA National Nutrient Database 
Porgy N/A N/A N/A USDA National Nutrient Database 
Tilapia N/A N/A N/A USDA National Nutrient Database 
Whitefish N/A N/A N/A USDA National Nutrient Database 
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Supplemental Material, Table 2: Coefficients and statistical significance of covariates in base models of log-transformed nerve 
conduction function 
Ln(nerve 
function) Model Adj-R2 Intercept Age a Femalea BMIb Hand Tempa 
Left-
handedc Weighta Heighta 
Foot 
Tempa 
Urine Hair 
Median peak 
latency 
1 0.21 1.72 0.004  0.006 -0.03       
2 0.22 1.76 0.004  0.006 -0.03     -0.0003 -0.01 
3 0.22 1.72 0.004  0.006 -0.03     -0.002  
4 0.22 1.73 0.004   0.006 -0.03           -0.01 
              
Ulnar peak 
latency 
1 0.36 2.12 0.002 -0.05 -0.001 -0.031       
2 0.34 2.12 0.002 -0.05 -0.001 -0.031     0.006 -0.01 
3 0.35 2.12 0.002 -0.05 -0.001 -0.031     0.006  
4 0.34 2.12 0.002 -0.05 -0.001 -0.029           -0.008 
              
Sural peak 
latency 
1 0.26 1.85 0.002      0.004 -0.04   
2 0.26 1.80 0.002      0.004 -0.04 -0.003 -0.02c 
3 0.25 1.83 0.002      0.004 -0.04 -0.004  
4 0.25 1.82 0.002           0.004 -0.04   -0.021b 
              
Median 
amplitude 
1 0.46 4.40 -0.02 0.31 -0.02  0.20      
2 0.47 4.40 -0.02 0.33 -0.02  0.20    -0.04c 0.08c 
3 0.46 4.40 -0.02 0.31 -0.02  0.20    -0.03  
4 0.47 4.31 -0.02 0.35 -0.02   0.20         0.06 
              
Ulnar 
amplitude 
1 0.53 5.40 -0.02 0.51 -0.01 -0.045 0.16      
2 0.52 5.40 -0.02 0.51 -0.01 -0.045 0.16    -0.02 0.07c 
3 0.52 5.40 -0.02 0.51 -0.01 -0.045 0.16    -0.01  
4 0.52 5.40 -0.02 0.51 -0.01 -0.045 0.16         0.06 
              
Sural 
amplitude 
1 0.25 4.83 -0.02     -0.007 -0.005    
2 0.28 5.09 -0.02     -0.007 -0.005  0.01 0.09c 
3 0.27 5.01 -0.02     -0.007 -0.005  0.02  
4 0.28 4.83 -0.02     -0.007 -0.005   0.09c 
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a p<0.0001; b p<0.01; c p<0.05 
Model 1: with no adjustment of mercury level in urine or hair 
Model 2: with adjustment of mercury level in both urine and hair 
Model 3: with adjustment of mercury level in urine 
Model 4: with adjustment of mercury level in hair 
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Supplemental Material, Figure 1: Correlations of hair mercury levels with estimated PUFA, EPA, and DHA levels 
 
 
